The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.
Steckelings UM, Widdop RE, Sturrock ED, Lubbe L, Hussain T, Kaschina E, Unger T, Hallberg A, Carey RM, Sumners C.
Steckelings UM, et al.
Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281.
Pharmacol Rev. 2022.
PMID: 36180112
Free PMC article.
Review.